G. Thurman

发表

DOES THE SEVERITY OF RADIONUCLIDE-INDUCED SKELETAL MALIGNANCY DEPEND UPON RADIATION DOSE?

R. D. Lloyd, S. Miller, R. Lloyd, 2005, Health physics.

Familial thymic aplasia. Attempted reconstitution with fetal thymus in a Millipore diffusion chamber.

J. Bellanti, R. Steele, C. Limas, 1972, The New England journal of medicine.

Cultured cell lines from human breast cancer biopsies and xenografts

R. Oldham, G. Thurman, W. Lewko, 1990, Breast Cancer Research and Treatment.

Functional studies on the anti-pathoangiogenic properties of CM101

K. Washington, D. Page, F. Yakes, 2004, Angiogenesis.

Plutonium-induced osteosarcomas in the St. Bernard.

C. W. Mays, D. R. Atherton, G. Thurman, 1981, Radiation research.

Potent activation of mouse macrophages by recombinant interferon-gamma.

J. Talmadge, R. Wiltrout, R. Herberman, 1984, Cancer research.

Cytotoxicity inhibition studies using 3 M KCl solubilized murine histocompatibility antigens and a new multiple automated sample harvester.

Ahmed Awad E. Ahmed, K. Sell, D. Strong, 1973, Journal of immunological methods.

Production of biologically active N alpha-desacetylthymosin alpha 1 in Escherichia coli through expression of a chemically synthesized gene.

H. Heyneker, P. Jhurani, R. Wetzel, 1980, Biochemistry.

Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

C. Lai, A. Goldstein, J. Meienhofer, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer

J. Talmadge, K. Foon, R. Oldham, 1984, Cancer.

MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.

P. Gray, R. Oldham, I. Braude, 1985, Journal of immunology.

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

C. Hellerqvist, H. Sundell, G. Thurman, 2005, Journal of Cancer Research and Clinical Oncology.

Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor.

K. Sell, F. Bach, R. Hartzman, 1972, Cellular immunology.

EXAMINATION OF LYMPHOCYTE MEMBRANES OF ATHYMIC “NUDE” MICE BY SCANNING ELECTRON MICROSCOPY *

A. Goldstein, P. Baur, G. Thurman, 1975, Annals of the New York Academy of Sciences.

Current status of thymosin and other hormones of the thymus gland.

A. Goldstein, T. Low, J. Chen, 1981, Recent progress in hormone research.

Characterization of a human blood monocyte subset with low peroxidase activity.

Jo, C. Oliver, Paul, 1983, The Journal of clinical investigation.

Acute inflammatory changes in subcutaneous microtumors in the ears of mice induced by intravenous CM101 (GBS toxin)

D. Page, M. Kasami, L. Wilkinson, 2005, Journal of Cancer Research and Clinical Oncology.

Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors.

R. Oldham, H. Stevenson, G. Thurman, 1983, Journal of immunological methods.

A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation (CCE).

R. Herberman, R. Oldham, H. Stevenson, 1983, Journal of immunological methods.

CLINICAL TRIALS WITH THYMOSIN

A. Goldstein, J. Hokanson, J. Costanzi, 1979, Annals of the New York Academy of Sciences.

The effect of thymosin on patients with disseminated malignancies. A phase I study

A. Goldstein, J. Costanzi, G. Thurman, 1977, Cancer.

Thymosin-induced recovery of murine T-cell functions following treatment with hydrocortisone acetate.

A. Goldstein, J. Rossio, G. Thurman, 1977, Transplantation proceedings.

Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.

J. Adams, J. Talmadge, M. Schneider, 1985, Journal of immunology.

Enhancement of human lymphokine-activated killer cell cytolysis and a method for increasing lymphokine-activated killer cell yields to cancer patients.

J. Yannelli, R. Oldham, W. West, 1988, Cancer research.

Activation and expansion of tumor-derived activated cells for therapeutic use.

J. Yannelli, R. Oldham, A. Sferruzza, 1989, Journal of the National Cancer Institute.

A simple and versatile harvesting device for processing radioactive label incorporated into and-or released from cells in microculture.

M. Harrison, G. Thurman, G. Thomas, 1974, Journal of immunological methods.

THE ENDOCRINE THYMUS: POTENTIAL ROLE FOR THYMOSIN IN THE TREATMENT OF AUTOIMMUNE DISEASE *

A. Goldstein, J. Rossio, G. Thurman, 1976, Annals of the New York Academy of Sciences.

The effects of organic compounds used in the manufacture of plastics on the responsivity of murine and human lymphocytes.

D. J. Kilian, A. Goldstein, G. Thurman, 1978, Toxicology and applied pharmacology.

Skeletal location of radiation-induced and naturally occurring osteosarcomas in man and dog.

C. W. Mays, H. Sissons, G. Thurman, 1973, Cancer research.

Growth dynamics of beagle osteosarcomas.

C. W. Mays, W. R. Christensen, G. Thurman, 1971, Growth.

Biological Modifiers’ Potential for Radioprotection

R. Oldham, G. Thurman, 1991 .

T-LYMPHOCYTE MATURATION: CELL SURFACE BY T-LYMPHOCYTE CELL-FREE PRODUCTS MARKERS AND IMMUNE FUNCTION INDUCED AND THYMOSIN POLYPEPTIDES

Aftab J. Ahmed, A. Goldstein, T. Low, 2006 .

T‐LYMPHOCYTE MATURATION: CELL SURFACE MARKERS AND IMMUNE FUNCTION INDUCED BY T‐LYMPHOCYTE CELL‐FREE PRODUCTS AND THYMOSIN POLYPEPTIDES

Aftab J. Ahmed, A. Goldstein, T. Low, 1979, Annals of the New York Academy of Sciences.

PURIFICATION AND PROPERTIES OF BOVINE THYMOSIN *

A. Goldstein, R. Schulof, G. Thurman, 1975, Annals of the New York Academy of Sciences.

CURRENT STATUS OF THYMOSIN RESEARCH: EVIDENCE FOR THE EXISTENCE OF A FAMILY OF THYMIC FACTORS THAT CONTROL T‐CELL MATURATION *

G. Marshall, A. Goldstein, T. Low, 1979, Annals of the New York Academy of Sciences.

The thymosins--preclinical and clinical studies with fraction V and alpha-I.

J. Talmadge, R. Oldham, R. Smalley, 1984, Cancer treatment reviews.

RECENT DEVELOPMENTS IN THE CHEMISTRY, BIOLOGY AND CLINICAL APPLICATIONS OF THYMOSIN

A. Goldstein, T. Low, N. Hall, 1981 .

A Multifaceted Role for Thymosin and its Composite Peptides in T-Cell Regulation

A. Goldstein, T. Low, G. Thurman, 1981 .

Cyclic nucleotide changes in murine lymphocytes following thymosin incubation in vitro.

A. Goldstein, P. Naylor, G. Thurman, 1979, Immunopharmacology.

RECENT DEVELOPMENTS IN THE CLASSIFICATION AND BIOASSAY OF THYMOSIN POLYPEPTIDES

G. Marshall, A. Goldstein, T. Low, 1979 .

Effect of thymosin and lipopolysaccharide on murine lymphocyte cyclic AMP.

A. Goldstein, A. C. Phillips, P. Naylor, 1978, JIM - Journal of Immunological Methods.

Increase of cyclic GMP induced in murine thymocytes by thymosin fraction 5.

A. Goldstein, H. Sheppard, P. Naylor, 1976, Biochemical and biophysical research communications.

Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.

A. Goldstein, J. Rossio, G. Thurman, 1976, The Medical clinics of North America.

Regulation of immune balance by thymosin: potential role in the development of suppressor T-cells.

A. Goldstein, J. Rossio, J. Hooper, 1976, Advances in experimental medicine and biology.

Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH).

A. Ahmed, K. Sell, R. Hartzman, 1973, Clinical and experimental immunology.

Lymphokines secreted from sodium periodate-treated lymphocytes.

G. Trivers, A. L. Goldstein, G. Thurman, 1980, Cellular immunology.

DEMONSTRATION OF A BLOCKING FACTOR IN THE PLASMA AND SPINAL FLUID OF PATIENTS WITH SUBACUTE SCLEROSING PANENCEPHALITIS

K. Sell, Aftab J. Ahmed, D. Strong, 1974, The Journal of experimental medicine.

Thymosins and other hormones of the thymus gland.

A. Goldstein, T. Low, R. Schulof, 1981, Progress in clinical and biological research.

CURRENT STATUS OF THYMOSIN RESEARCH: EVIDENCE FOR THE EXISTENCE OF A FAMILY OF THYMIC FACTORS THAT CONTROL T‐CELL MATURATION *

G. Marshall, A. Goldstein, T. Low, 1979, Annals of the New York Academy of Sciences.

The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus.

A. Goldstein, T. Low, J. Rossio, 1979, The Journal of biological chemistry.

Restorative effects of thymosin polypeptides on purified protein derivative--dependent migration inhibition factor production by the peripheral blood lymphocytes of adult thymectomized guinea pigs.

A. Goldstein, T. Low, G. Thurman, 1984, Journal of biological response modifiers.

In vitro stimulation of murine spleen cells using a microculture system and a multiple automated sample harvester.

Ahmed Awad E. Ahmed, K. Sell, D. Strong, 1973, Journal of immunological methods.

A. L. Goldstein, G. Thurman, H. Strausser, 1979, Journal of immunology.

Regulation of in vitro generation of cell-mediated cytotoxicity. II. Characterization of thymosin-induced suppressor T cells.

G. Marshall, A. Goldstein, G. Thurman, 1980, Immunopharmacology.

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.

G. Marshall, J. Yannelli, R. Oldham, 1987, The New England journal of medicine.

Cultured breast cystosarcoma phylloides cells and applications to patient therapy

R. Oldham, G. Thurman, W. Lewko, 1990, Breast Cancer Research and Treatment.

Chemosensitivity testing in a tumor acquisition, propagation, and preservation program.

R. Oldham, G. Thurman, W. Lewko, 1989, Molecular biotherapy.

Working Group IV: lipids and the immune system. Report and recommendations.

P. Newberne, G B Thurman, P M Newberne, 1981, Cancer research.

Correction of T cell function by thymosin in New Zealand mice.

A. Ahmed, A. Steinberg, M. Gershwin, 1974, Journal of immunology.

Thymosin and the immunopathology of aging.

A. Goldstein, M. Dardenne, A. White, 1974, Federation proceedings.

THE ROLE OF THYMOSIN AND THE ENDOCRINE THYMUS ON THE ONTOGENESIS AND FUNCTION OF T-CELLS*

A. Goldstein, J. Hooper, G. Thurman, 1975 .

In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.

G. Marshall, A. Goldstein, J. Rossio, 1981, Journal of immunology.

CM101, a polysaccharide antitumor agent, does not inhibit wound healing in murine models

C. Hellerqvist, G. Thurman, Anne Sundell, 2005, Journal of Cancer Research and Clinical Oncology.

Quantified color Doppler sonography of tumor vascularity in an animal model.

D R Pickens, E F Donnelly, D. Pickens, 1999, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

An improved method for the generation of human lymphokine activated killer cells.

J. Yannelli, R. Oldham, G. Thurman, 1987, Journal of immunological methods.

An Improved Method for the Generation of Human Activated Killer Cells

J. Yannelli, R. Oldham, W. West, 1987 .

The generation of human lymphokine-activated killer cells in various serum-free media.

J. Yannelli, M. Jadus, G. Thurman, 1988, Journal of immunological methods.

Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.

J. Talmadge, F. Ruscetti, J. Ortaldo, 1986, Journal of biological response modifiers.

LYMPHOCYTE ACTIVATION IN SUBACUTE SCLEROSING PANENCEPHALITIS VIRUS AND CYTOMEGALOVIRUS INFECTIONS

A. Ahmed, K. Sell, D. Strong, 1973, The Journal of experimental medicine.

Characterization of a method using viable human target cells as the solid phase in a cell concentration fluorescence immunoassay (CCFIA) for screening of monoclonal antibodies and hybridoma supernatants.

R. Oldham, S. Liao, G. Thurman, 1988, JIM - Journal of Immunological Methods.

Phase I study of the antineovascularization drug CM101.

C. Hellerqvist, D. Johnson, H. Sundell, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons.

R. Herberman, G. Thurman, 1983, Journal of biological response modifiers.

Occurrence of metastases in beagles with skeletal malignancies induced by internal irradiation.

R. D. Lloyd, S. Miller, G. Thurman, 1994, Health Physics.

Does age of the host affect growth rates of skeletal malignancies?

R. D. Lloyd, S. Miller, G. Thurman, 1998, Health physics.

Growth Dynamics of Osteosarcomas in Beagles.

G. Thurman, 1971 .

Hormonal influences on the reticuloendothelial system: current status of the role of thymosin in the regulation and modulation of immunity.

G. Trivers, A. Goldstein, T. Low, 1978, Journal of the Reticuloendothelial Society.

Evidence for the T cell specificity of sodium periodate-induced lymphocyte blastogenesis.

B. Giovanella, A. Goldstein, G. Thurman, 1974, Journal of immunology.

Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.

G. Marshall, A. Goldstein, T. Low, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Tumor acquisition, propagation, and preservation. The culture of human colorectal cancer

R. Oldham, G. Thurman, W. Lewko, 1989, Cancer.

Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results.

D. Pickens, A. Fleischer, C. Hellerqvist, 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Effect of thymosin on T-lymphocyte rosette formation in children with kwashiorkor.

A. Goldstein, S. Olusi, G. Thurman, 1980, Clinical immunology and immunopathology.

Effect of calcium on the cyclic GMP elevation induced by thymosin fraction 5.

A. Goldstein, P. Naylor, G. Thurman, 1979, Biochemical and biophysical research communications.

Immunoconjugates of doxorubicin and murine antihuman breast carcinoma monoclonal antibodies prepared via an N-hydroxysuccinimide active ester intermediate of cis-aconityl-doxorubicin: preparation and in vitro cytotoxicity.

R. Oldham, S. Liao, G. Thurman, 1989, Molecular biotherapy.

In vitro induction of Lyt surface markers on precursor cells incubated with thymosin polypeptides.

A. Ahmed, K. Sell, A. Goldstein, 1978, Cancer treatment reports.

Alterations in the mitogen responsiveness of lymphocytes from mice bearing Moloney sarcoma virus induced tumors.

G. Marshall, A. Goldstein, G. Thurman, 1977, Immunological communications.

Antitumor effects of GBS toxin: a polysaccharide exotoxin from group Bβ-hemolytic streptococcus

D. Page, C. Hellerqvist, H. Sundell, 2005, Journal of Cancer Research and Clinical Oncology.

Effects of group BStreptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumors

D. Page, C. Hellerqvist, H. Sundell, 2005, Journal of Cancer Research and Clinical Oncology.

LYMPHOCYTE ACTIVATION IN SUBACUTE SCLEROSING PANENCEPHALITIS VIRUS AND CYTOMEGALOVIRUS INFECTIONS

A. Ahmed, K. Sell, D. Strong, 1973, The Journal of experimental medicine.